Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.
FDA clears credit card-sized heart monitor
The new device was designed to help patients evaluate their own heart health in real time.
TAVR/PCI bests SAVR/CABG when treating severe AS and complex CAD
Percutaneous treatment was linked to improved survival and fewer adverse events than surgery when patients presented with both symptomatic severe aortic stenosis and complex coronary artery disease.
More vulnerable, but still treatable: Frail heart patients benefit from PCI, CABG
High-risk patients are often treated with medical therapy alone instead of revascularization. However, new data make it clear that these patients can live much longer when treated with PCI or CABG.
Genetic predisposition to depression increases CVD risk in women, but not men
The heightened risks were even seen in women who were never diagnosed with a psychiatric disorder. It remains unclear why the same trend was not seen in men.

Preterm births associated with increased risk of ischemic heart disease for the mother

The study's authors tracked data from more than 2 million women.

June 29, 2020

Protein boosts heart attack recovery, could be a game-changer for patients

There are approximately 20,000 proteins in the human heart—and one of them, if administered as a drug, could help patients recover more quickly following a myocardial infarction.

June 23, 2020

Spectacular science: 3D model offers breathtaking look at what happens during a heart attack

So what, exactly, occurs inside the human heart during a myocardial infarction?

June 12, 2020

Gene-editing specialists raise $63M to combat coronary heart disease

Verve Therapeutics, a healthcare company focused on improving cardiovascular outcomes through gene-editing technology, has raised $63 million in Series A2 financing.

June 11, 2020

Cardiologists urge heart disease patients to seek emergency care when necessary

Hospitals throughout the United States have reported that a general fear of COVID-19 has led to significant drops in patients presenting with heart attack symptoms and other cardiovascular issues.

June 2, 2020

FDA approves use of ticagrelor for high-risk CAD patients

Ticagrelor has been approved by the FDA for reducing the risk of a first heart attack or stroke in high-risk coronary artery disease (CAD) patients.

June 2, 2020

Evolocumab improves cardiovascular outcomes for patients with a recent MI

Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.

May 21, 2020

Heart attack care is different for male and female patients—and the inconsistency can lead to fatal results

Women are prescribed fewer drugs after a heart attack than men—and they are more likely to die afterward as a result of that disparity.

April 23, 2020

Acute Coronary Syndromes

Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

FDA clears credit card-sized heart monitor

TAVR/PCI bests SAVR/CABG when treating severe AS and complex CAD

More vulnerable, but still treatable: Frail heart patients benefit from PCI, CABG

Genetic predisposition to depression increases CVD risk in women, but not men